Ron Frieson - 01 Nov 2021 Form 3 Insider Report for Akebia Therapeutics, Inc. (AKBA)

Role
Director
Signature
/s/ Carolyn Rucci, attorney-in-fact for Ronald E. Frieson
Issuer symbol
AKBA
Transactions as of
01 Nov 2021
Net transactions value
$0
Form type
3
Filing time
03 Nov 2021, 16:45:21 UTC
Next filing
09 Jun 2022

No securities are beneficially owned.